Life Technologies Acquires Pinpoint Genomics and CLIA-Approved Lung C... ( CARLSBAD Calif. July 25 2012 /- ...)

Life Technologies Acquires Pinpoint Genomics and CLIA-Approved Lung Cancer Test

Date:7/25/2012

CARLSBAD, Calif., July 25, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced the acquisition of Pinpoint Genomics, Inc., and its early-stage non-small cell lung cancer test that can help doctors identify those early-stage patients at high risk for progression to late-stage disease. Lung cancer is currently the leading cause of cancer deaths worldwide, claiming close to 1.5 million lives every year.

Early-Stage Lung Cancer Diagnostic Could Save Lives

"Although we've realized impressive gains against many forms of cancer, the survival rate for lung cancer hasn't changed in 30 years," said Ronnie Andrews, president of medical sciences at Life Technologies. "Half of the early-stage patients don't survive beyond five years, a situation that could benefit from more accurate prognosis and more efficient treatment protocols."

Lung cancer is currently diagnosed and staged by a combination of tumor size, location and the extent of spread to lymph nodes. The current standard of care for most stage I disease is surgery followed by monitoring, otherwise known as "watchful waiting." The National Comprehensive Cancer Network recommends that both Stage II and the highest risk Stage IB patients be treated with adjuvant chemotherapy.

"Data from the Pinpoint assay will fill a gap of insufficient prognostic information, and help physicians and their early-stage patients, who face very difficult decisions regarding post-operative therapy, to make better, individualized plans," said Michael Mann, M. D., an associate professor of cardiothoracic surgery at the University of California, San Francisco and a co-founder of Pinpoint Genomics. "It should therefore facilitate more effective implementation of current guidelines."

The problem, he explains, is that conventional staging co
'/>"/>

SOURCE Life Technologies Corporation
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6
Related medicine technology :

1. Life Technologies and SATuRN Collaborate to Increase Access to HIV Testing in Africa
2. Life Technologies Develops Simplified SAME-DAY STEC Solution for Detecting Multiple Strains of E. coli in Ground Beef
3. Ellman International Launches Multi-stage Growth Plan With Acquisition Of Sandstone Medical Technologies
4. Lifeline Biotechnologies First Warning Systems
5. Life Technologies Signs Collaborative Agreement with Structural Genomics Consortium to Develop First Antibody Master Set for Epigenetic Studies
6. Acquisition of Navigenics Expands Life Technologies Capabilities in Diagnostics
7. Medisafe 1 Technologies Corp has of Today Acquired 3,100,000 Shares and Continues to Acquire Shares Under its $1MM Stock Repurchase Program of 10MM Shares up to 10 Cents a Share to Facilitate its On-going Acquisitions Activity Plan
8. Dehaier Medical Receives Software Copyrights for Four Proprietary Technologies
9. CSS Health Technologies Hires Industry Leader as New Senior Vice President of Sales
10. Ancor and Merit acquire Uplift Technologies for Carex Health Brands
11. Ultra Clean Holdings, Inc. Completes Strategic Merger with Advanced Integration Technologies

Post Your Comments:

(Date:6/17/2013)... As the Share Repurchase Resolution has been passed at ... Corporation, plc (NYSE: ELN ) has lapsed in ... Proceedings referred to below and any consequent decision of the ... to the extent that it would have been had it ... Repurchase Resolution being passed. There can be no assurance as ...

(Date:6/17/2013)... Mass. , and SYDNEY ... Inc. (Nasdaq: HTWR ; ASX: HIN), ... support technologies that are revolutionizing the treatment of ... Food and Drug Administration (FDA) has granted conditional ... that allows HeartWare to commence enrollment in an ...

(Date:6/17/2013)... Perrigo Company (NYSE: PRGO ; ... agreement to acquire and has completed the acquisition of ... Fera Pharmaceuticals, LLC and its affiliates (Fera), a privately-held, ... pharmaceutical company. The acquired portfolio, including nine prescription ANDA ... during calendar year 2012. Terms of the transaction include ...

[0] Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today [0] HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial [0] Perrigo Company Acquires Ophthalmic Product Portfolio From Fera Pharmaceuticals, LLC For An Upfront Payment Of $93 Million

... YORK , Aug. 2 Reportlinker.com announces that a new market research report is ... Hepatitis C Therapeutics ... http://www.reportlinker.com/p0236386/Hepatitis-C-Therapeutics-Market---Taiwan.html , ... This research service aims to provide an update on ...

... SHANGHAI , Aug. 2 /PRNewswire-Asia/ -- WuXi ... a leading research and development outsourcing company serving the,pharmaceutical, ... the United States , today announced its financial ... . , (Logo: http://photos.prnewswire.com/prnh/20040705/CNM002LOGO ...

Hepatitis C Therapeutics Market - Taiwan WuXi PharmaTech Announces Second-Quarter 2010 Results

(Date:6/17/2013)... June 17, 2013 Nearly 26 million ... many as 79 million adults are estimated to have ... prevent type 2 diabetes through weight loss and lifestyle ... help bring your blood sugar level back within the ... factors, 101 Medical Weight Loss physicians can help tailor ...

(Date:6/17/2013)... NY (PRWEB) June 17, 2013 ... & Murphy, LLP are pleased to announce that ... and David L. Scher ( http://www.blockotoole.com/Attorneys/David-L-Scher.shtml ) will ... Z100 (100.3 FM) this Sunday, June 23, 2013 ... will be guests on Kevin Burke's "Get Active" ...

(Date:6/17/2013)... 17, 2013 The producers of Impact ... series of reports highlighting how sustainable farming techniques are ... populations and their demand on food supplies. , ... television series airing in markets around the country on ... Martin Sheen, who is marking the start of his ...

(Date:6/17/2013)... (PRWEB) June 17, 2013 Dallas-based physician ... the nation to offer the hybrid concierge model from ... model to offer her patients a wider variety of ... and a greater emphasis on prevention and wellness had ... who want a concierge-style of medicine, but doesn't force ...

(Date:6/17/2013)... Stem Cell Institute (HSCI) researchers have identified in the ... regulate embryonic stem cell self-renewal, beginning a creative search ... The gene, SALL4, gives stem cells their ability to ... cells. Typically, cells only express SALL4 during embryonic development, ... of acute myeloid leukemia and 10 to 30 percent ...

Breaking Medicine News(10 mins):Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 2 Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 3 Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 4 Health News:Injury Attorneys Block O'Toole & Murphy, LLP to Appear on Z100 Radio Show This Sunday to Discuss Their Support of St. Jude Children's Research Hospital 2 Health News:Dr. Casad Offers Hybrid Concierge Model from Concierge Choice Physicians 2 Health News:Dr. Casad Offers Hybrid Concierge Model from Concierge Choice Physicians 3 Health News:A new target for cancer drug development 2

[0] Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss [0] Injury Attorneys Block O'Toole & Murphy, LLP to Appear on Z100 Radio Show This Sunday to Discuss Their Support of St. Jude Children's Research Hospital [0] The Producers of Impact Martin Sheen for PBS Member Stations Announce a New Series on Sustainable Agriculture [0] Dr. Casad Offers Hybrid Concierge Model from Concierge Choice Physicians [0] A new target for cancer drug development

... its determination to gear up to meet the avian flu ... keep a close watch on bird flu cases and also ... M A Hakeem said "Though we have no cases of ... measures and the committee to be formed will include representatives ...

... a high childhood IQ irrespective of income and social position. ... and Laura Kubzansky, Harvard's School of Public Health who reported ... ,Childhood IQ of more than 163 score is very ... with a score more than 130 are considered gifted and ...

... cancers are mainly caused by cigarette smoking and smoking ... occurrence. In order to reduce the risk of cigarette ... of testing //their new range of “safer cigarette” which ... ,The company is testing their new ...

... practical and cost effective new way to combat the HIV ... modified bacteria living in the human body to produce chemicals ... occurs on the surfaces of the gut and reproductive areas, ... ,The researchers have successfully modified one of these bacteria ...

... age-related macular degeneration and the genetic mechanisms underlying the ... identification of a bacterium //called Chlamydia pneumoniae in the ... notable that the microorganism is associated with chronic inflammation ... in the diseased eye tissue of five of nine ...

... of bird flu in the famous Ranganathittu bird sanctuary ... Department today said that it was totally geared up ... ,The Department has taken precautionary measures against bird flu ... several countries including Central and Northern China, Russia, Mongolia, ...

Cached Medicine News:Health News:Avian Influenza: Government to set up expert committee 2 Health News:Genetically modified bacteria to combat HIV 2 Health News:Bird flu threat ruled out: Karnataka Forest Department, 2

Avian Influenza: Government to set up expert committee Intelligent children had longer live British company developing ‘Safer Cigarettes Genetically modified bacteria to combat HIV Vision Loss in Elderly Caused By Combined Effect of Genes and Bacterium Bird flu threat ruled out: Karnataka Forest Department,

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

Medicine Products:

Retinol Binding Protein Restoril Respiratory Syncytial Virus DFA Reserpine, Serum or Plasma